Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

The 20 Most-Frequently Read Articles
Category: All

in J Clin Oncol during March 2015 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on abstract, full-text and pdf views.

1.  Ryo Kitagawa, Noriyuki Katsumata, Taro Shibata, Toshiharu Kamura, Takahiro Kasamatsu, Toru Nakanishi, Sadako Nishimura, Kimio Ushijima, Masashi Takano, Toyomi Satoh, Hiroyuki Yoshikawa
  Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
  J. Clin. Oncol. Mar 02, 2015; doi: 10.1200/JCO.2014.58.4391.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
2.  Gregory A. Masters, Lada Krilov, Howard H. Bailey, Marcia S. Brose, Harold Burstein, Lisa R. Diller, Don S. Dizon, Howard A. Fine, Gregory P. Kalemkerian, Mark Moasser, Michael N. Neuss, Steven J. O''Day, Olatoyosi Odenike, Charles J. Ryan, Richard L. Schilsky, Gary K. Schwartz, Alan P. Venook, Sandra L. Wong, Jyoti D. Patel
  Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
  J. Clin. Oncol. Mar 01, 2015; 33: 786-809.
(In "ASCO SPECIAL ARTICLES")   [Full Text]     [PDF]
 
3.  Carsten Denkert, Gunter von Minckwitz, Jan C. Brase, Bruno V. Sinn, Stephan Gade, Ralf Kronenwett, Berit M. Pfitzner, Christoph Salat, Sherene Loi, Wolfgang D. Schmitt, Christian Schem, Karin Fisch, Silvia Darb-Esfahani, Keyur Mehta, Christos Sotiriou, Stephan Wienert, Peter Klare, Fabrice André, Frederick Klauschen, Jens-Uwe Blohmer
  Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
  J. Clin. Oncol. Mar 20, 2015; 33: 983-991.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
4.  Gary H. Lyman, Kari Bohlke, Alok A. Khorana, Nicole M. Kuderer, Agnes Y. Lee, Juan Ignacio Arcelus, Edward P. Balaban, Jeffrey M. Clarke, Christopher R. Flowers, Charles W. Francis, Leigh E. Gates, Ajay K. Kakkar, Nigel S. Key, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Sandra L. Wong, Mark R. Somerfield, Anna Falanga
  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
  J. Clin. Oncol. Feb 20, 2015; 33: 654-656.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
5.  Marie A. Bakitas, Tor D. Tosteson, Zhigang Li, Kathleen D. Lyons, Jay G. Hull, Zhongze Li, J. Nicholas Dionne-Odom, Jennifer Frost, Konstantin H. Dragnev, Mark T. Hegel, Andres Azuero, Tim A. Ahles
  Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial
  J. Clin. Oncol. Mar 23, 2015; doi: 10.1200/JCO.2014.58.6362.
(In "Palliative and Supportive Care")   [Abstract]     [Full Text]     [PDF]
 
6.  Eric Van Cutsem, Heinz-Josef Lenz, Claus-Henning Köhne, Volker Heinemann, Sabine Tejpar, Ivan Melezínek, Frank Beier, Christopher Stroh, Philippe Rougier, J. Han van Krieken, Fortunato Ciardiello
  Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <I>RAS</I> Mutations in Colorectal Cancer
  J. Clin. Oncol. Mar 01, 2015; 33: 692-700.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
7.  Julien Mazi&egrave;res, G&eacute;rard Zalcman, Lucio Crin&ograve;, Pamela Biondani, Fabrice Barlesi, Thomas Filleron, Anne-Marie C. Dingemans, Herv&eacute; L&eacute;na, Isabelle Monnet, Sacha I. Rothschild, Federico Cappuzzo, Benjamin Besse, Luc Thiberville, Damien Rouvi&egrave;re, Rafal Dziadziuszko, Egbert F. Smit, Jurgen Wolf, Christian Spirig, Nicolas Pecuchet, Frauke Leenders
  Crizotinib Therapy for Advanced Lung Adenocarcinoma and a <I>ROS1</I> Rearrangement: Results From the EUROS1 Cohort
  J. Clin. Oncol. Mar 20, 2015; 33: 992-999.
(In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
 
8.  Karen A. Gelmon, Frances M. Boyle, Bella Kaufman, David G. Huntsman, Alexey Manikhas, Angelo Di Leo, Miguel Martin, Lee S. Schwartzberg, Julie Lemieux, Samuel Aparicio, Lois E. Shepherd, Susan Dent, Susan L. Ellard, Katia Tonkin, Kathleen I. Pritchard, Timothy J. Whelan, Dora Nomikos, Arnd Nusch, Robert E. Coleman, Hirofumi Mukai
  Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2&#8211;Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31
  J. Clin. Oncol. Mar 16, 2015; doi: 10.1200/JCO.2014.56.9590.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
9.  Michael A. Postow, Margaret K. Callahan, Jedd D. Wolchok
  Immune Checkpoint Blockade in Cancer Therapy
  J. Clin. Oncol. Jan 20, 2015; doi: 10.1200/JCO.2014.59.4358.
(In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
10.  Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Franco Cavalli, Lawrence H. Schwartz, Emanuele Zucca, T. Andrew Lister
  Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
  J. Clin. Oncol. Sep 20, 2014; 32: 3059-3067.
(In "SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
11.  Michele Maio, Jean-Jacques Grob, Steinar Aamdal, Igor Bondarenko, Caroline Robert, Luc Thomas, Claus Garbe, Vanna Chiarion-Sileni, Alessandro Testori, Tai-Tsang Chen, Marina Tschaika, Jedd D. Wolchok
  Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
  J. Clin. Oncol. Apr 01, 2015; 33: 1191-1196.
(In "Melanoma")   [Abstract]     [Full Text]     [PDF]
 
12.  Ginah Nightingale, Emily Hajjar, Kristine Swartz, Jocelyn Andrel-Sendecki, Andrew Chapman
  Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer
  J. Clin. Oncol. Mar 23, 2015; doi: 10.1200/JCO.2014.58.7550.
(In "Clinical Practice")   [Abstract]     [Full Text]     [PDF]
 
13.  Cliff G. Robinson, Aalok P. Patel, Jeffrey D. Bradley, Todd DeWees, Saiama N. Waqar, Daniel Morgensztern, Maria Q. Baggstrom, Ramaswamy Govindan, Jennifer M. Bell, Tracey J. Guthrie, Graham A. Colditz, Traves D. Crabtree, Daniel Kreisel, Alexander S. Krupnick, G. Alexander Patterson, Bryan F. Meyers, Varun Puri
  Postoperative Radiotherapy for Pathologic N2 Non&#8211;Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base
  J. Clin. Oncol. Mar 10, 2015; 33: 870-876.
(In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
 
14.  Gideon M. Blumenthal, Stella W. Karuri, Hui Zhang, Lijun Zhang, Sean Khozin, Dickran Kazandjian, Shenghui Tang, Rajeshwari Sridhara, Patricia Keegan, Richard Pazdur
  Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non&#8211;Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses
  J. Clin. Oncol. Mar 20, 2015; 33: 1008-1014.
(In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
 
15.  Barbara Gomes
  Palliative Care: If It Makes a Difference, Why Wait?
  J. Clin. Oncol. Mar 23, 2015; doi: 10.1200/JCO.2014.60.5386.
(In "EDITORIALS")   [Full Text]     [PDF]
 
16.  Miguel Mart&iacute;n, Sibylle Loibl, Gunter von Minckwitz, Seraf&iacute;n Morales, Noelia Martinez, Angel Guerrero, Antonio Anton, Bahriye Aktas, Winfried Schoenegg, Montserrat Mu&ntilde;oz, Jos&eacute; &Aacute;ngel Garcia-Saenz, Miguel Gil, Manuel Ramos, Mireia Margeli, Eva Carrasco, Cornelia Liedtke, Grischa Wachsmann, Keyur Mehta, Juan R. De la Haba-Rodriguez
  Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy As First-Line Treatment for Advanced Breast Cancer: The Letrozole/Fulvestrant and Avastin (LEA) Study
  J. Clin. Oncol. Mar 20, 2015; 33: 1045-1052.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
17.  Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, Mark Raffeld, Betsy Morrow, Ronan Kelly, Corey Allan Carter, Udayan Guha, Keith Killian, Christopher C. Lau, Zied Abdullaev, Liqiang Xi, Svetlana Pack, Paul S. Meltzer, Christopher L. Corless, Alan Sandler, Carol Beadling, Andrea Warrick, David J. Liewehr, Seth M. Steinberg
  Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
  J. Clin. Oncol. Mar 20, 2015; 33: 1000-1007.
(In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
 
18.  Laurence Klotz, Chris O''Callaghan, Keyue Ding, Paul Toren, David Dearnaley, Celestia S. Higano, Eric Horwitz, Shawn Malone, Larry Goldenberg, Mary Gospodarowicz, Juanita M. Crook
  Nadir Testosterone Within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Trial of Intermittent Versus Continuous ADT
  J. Clin. Oncol. Apr 01, 2015; 33: 1151-1156.
(In "Urologic Oncology")   [Abstract]     [Full Text]     [PDF]
 
19.  Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L. Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain, Alan C. Hartford, Afshin Rashtian, Eleanor M. Walker, Albert Yuen, Eric A. Strom, Jeannette L. Wilcox, Laura A. Vallow, William Small, Anthony T. Pu, Kevin Kerlin
  RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation
  J. Clin. Oncol. Mar 01, 2015; 33: 709-715.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
20.  Neal E. Ready, Herbert H. Pang, Lin Gu, Gregory A. Otterson, Sachdev P. Thomas, Antonius A. Miller, Maria Baggstrom, Gregory A. Masters, Stephen L. Graziano, Jeffrey Crawford, Jeffrey Bogart, Everett E. Vokes
  Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study&#8212;CALGB 30504 (Alliance)
  J. Clin. Oncol. Mar 02, 2015; doi: 10.1200/JCO.2014.57.3105.
(In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
 
  
rss gif Subscribe to Most Read feed

Last Updated: 04/04/2015 15:52:20

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2015 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online